BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 20884251)

  • 1. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
    Ping SY; Wu CL; Yu DS
    Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
    Wu CL; Ping SY; Yu CP; Yu DS
    Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation.
    Yu DS; Wu CL; Ping SY; Keng C; Shen KH
    Kaohsiung J Med Sci; 2015 Aug; 31(8):391-7. PubMed ID: 26228277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sunitinib malate on growth of human bladder transitional cell line T24 in vitro.
    Wen J; Li HZ; Ji ZG; Jin J
    Chin Med Sci J; 2015 Mar; 30(1):51-5. PubMed ID: 25837361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.
    Chen F; Langenstroer P; Zhang G; Iwamoto Y; See W
    J Urol; 2003 Nov; 170(5):2009-13. PubMed ID: 14532843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of vascular endothelial growth factor a dynamic expression in transitional cell carcinoma.
    Ping SY; Shen KH; Yu DS
    Mol Carcinog; 2013 Jul; 52(7):568-79. PubMed ID: 22392726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell].
    Li X; Gong ZY; Li H; Wei Q; Shi M; Yang YR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):177-81. PubMed ID: 15062066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B is involved in the apoptosis intrinsic pathway induced by Bacillus Calmette-Guérin in transitional cancer cell lines.
    Sandes E; Lodillinsky C; Cwirenbaum R; Argüelles C; Casabé A; Eiján AM
    Int J Mol Med; 2007 Dec; 20(6):823-8. PubMed ID: 17982689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury.
    Chen F; Zhang G; Cao Y; Payne R; See WA
    J Urol; 2007 Nov; 178(5):2166-70. PubMed ID: 17870116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
    Jin D; Cao M; Mu X; Yang G; Xue W; Huang Y; Chen H
    Cell Biochem Biophys; 2015 Apr; 71(3):1349-56. PubMed ID: 25388838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway.
    Zhang G; Chen F; Cao Y; See WA
    Urol Oncol; 2007; 25(3):221-7. PubMed ID: 17483019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts.
    Peng CC; Chen KC; Peng RY; Su CH; Hsieh-Li HM
    Cancer Lett; 2006 Nov; 243(1):109-19. PubMed ID: 16455193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2.
    Perabo FG; Wirger A; Kamp S; Lindner H; Schmidt DH; Müller SC; Kohn EC
    Anticancer Res; 2004; 24(5A):2869-77. PubMed ID: 15517890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis by Chan Su, a traditional Chinese medicine, in human bladder carcinoma T24 cells.
    Ko WS; Park TY; Park C; Kim YH; Yoon HJ; Lee SY; Hong SH; Choi BT; Lee YT; Choi YH
    Oncol Rep; 2005 Aug; 14(2):475-80. PubMed ID: 16012733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways.
    Lyros O; Mueller A; Heidel F; Schimanski CC; Gockel I; Galle PR; Lang H; Moehler M
    Int J Cancer; 2010 Sep; 127(5):1197-208. PubMed ID: 20039326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
    Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
    World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hispidulin potentiates the antitumor effect of sunitinib against human renal cell carcinoma in laboratory models.
    Gao H; Jiang Q; Han Y; Peng J; Wang C
    Cell Biochem Biophys; 2015 Mar; 71(2):757-64. PubMed ID: 25260394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD.
    Saito Y; Tanaka Y; Aita Y; Ishii KA; Ikeda T; Isobe K; Kawakami Y; Shimano H; Hara H; Takekoshi K
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(6):E615-25. PubMed ID: 21878661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.